Sleep status of cervical cancer patients and predictors of poor sleep quality during adjuvant therapy

2014 ◽  
Vol 23 (5) ◽  
pp. 1401-1408 ◽  
Author(s):  
Jun Tian ◽  
Gui Lin Chen ◽  
Hai Rong Zhang
Keyword(s):  
Cervical Cancer ◽  
Adjuvant Therapy ◽  
Sleep Quality ◽  
Cancer Patients ◽  
Poor Sleep ◽  
Poor Sleep Quality

scholarly journals Predictors of poor sleep quality among head and neck cancer patients

2010 ◽  
pp. n/a-n/a ◽  
Author(s):  
Andrew G. Shuman ◽  
Sonia A. Duffy ◽  
David L. Ronis ◽  
Susan L. Garetz ◽  
Scott A. McLean ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Sleep Quality ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Poor Sleep ◽  
Poor Sleep Quality

Chất lượng giấc ngủ và các yếu tố liên quan ở bệnh nhân ung thư tại Bệnh viện Trường Đại học Y Dược Huế

2021 ◽  
Author(s):  
Xuan Dung Ho
Keyword(s):  
Sleep Quality ◽  
Cancer Patients ◽  
Linear Regression Analysis ◽  
Anxiety And Depression ◽  
Poor Sleep ◽  
Quality Of Sleep ◽  
Poor Sleep Quality ◽  
Related Factors ◽  
Falling Asleep

TÓM TẮT Giới thiệu: Các rối loạn về giấc ngủ: khó khăn khi đi vào giấc ngủ, duy trì giấc ngủ, chất lượng giấc ngủ kém, dậy sớm và ngủ ban ngày quá nhiều mà bệnh nhân ung thư phải trải qua thường xuyên nhưng thường hay bị bỏ sót và chưa được chú ý đến. Mục tiêu: Đánh giá chất lượng giấc ngủ và tìm hiểu các yếu tố liên quan đến chất lượng giấc ngủ ở bệnh nhân ung thư đang được điều trị tại bệnh viện trường đại học Y dược Huế. Phương pháp nghiên cứu: Phương pháp nghiên cứu cắt ngang trên 104 bệnh nhân ung thư tại Khoa Ung Bướu, bệnh viện trường Đại học Y dược Huế. Sử dụng thang đo PSQI và PHQ-ADS để đánh giá chất lượng giấc ngủ, và tình trạng trầm cảm lo âu ở bệnh nhân ung thư. Phân tích hồi quy đa biến tuyến tính dùng để kiểm định mối tương quan giữa chất lượng giấc ngủ và các yếu tố liên quan. Kết quả: Đối tượng nghiên cứu có độ tuổi trung bình 59,6 ± 11,7. Điểm PSQI trung bình chất lượng giấc ngủ là 10,6 ± 5,2. Phần lớn bệnh nhân có chất lượng giấc ngủ kém (79,8%); trong đó, 50% bệnh nhân gặp trở ngại lớn để đi vào giấc ngủ, có đến 46,2% chỉ ngủ được 5 giờ trong một đêm. Có mối liên quan có ý nghĩa thống kê giữa chất lượng giấc ngủ với giới tính và tình trạng trầm cảm, lo âu (p < 0,05). Kết luận: Bệnh nhân ung thư thường có chất lượng giấc ngủ kém. Điều này cho thấy giấc ngủ của bệnh nhân cần được quan tâm đúng mức và không nên bỏ sót trong quá trình chẩn đoán và điều trị. Từ khóa: Chất lượng giấc ngủ, bệnh nhân ung thư, trầm cảm lo âu. ABSTRACT QUALITY OF SLEEP AND RELATED FACTORS AMONG CANCER PATIENTS IN HUE UNIVERSITY HOSPITAL Introduction: Sleep disorders such as difficulty in falling asleep, maintaining sleep, poor sleep efficiency, early awakening and excessive daytime sleepiness are among the adverse effects that are experienced frequently but they are widely underdiagnosed. Therefore, addressing problems related to sleep among cancer patients could carry out better implications to improve quality of sleep, enhancing treatment outcomes. Aim: To evaluate quality of sleep and to detect associated factors of sleep quality among cancer patients. Methods: The cross-sectional study was conducted among 104 cancer patients treated at the Oncology Department, Hue University of Medicine and Pharmacy hospital. Sleep quality (Pittsburgh Sleep Quality Index), severity of anxiety and depression (Patient Health Questionnaire - Anxiety and Depression Scale) were accessed in the present study. Linear regression analysis was used to investigate the association between sleep quality and its related factors. Results: The mean age of study population was 59.6 ± 11.7. The average PSQI score was 10.6 ± 5.2. 79.8% cancer patients had poor sleep quality (PSQI score > 5). 50% patients had difficulty falling asleep and 46.2% patients reported sleep of < 5 hours per day. There were statistically associations between quality of sleep and gender, depression/anxiety (p < 0.05). Conclusion: The majority of cancer patients had poor sleep quality. This study points out that sleep is of great importance among cancer patients, which should not be neglected during the diagnosis and treatment procedure. Keyword: Quality of sleep, cancer patient, depression, anxiety.

Chất lượng giấc ngủ và các yếu tố liên quan ở bệnh nhân ung thư tại Bệnh viện Trường Đại học Y Dược Huế

2021 ◽  
Author(s):  
Mai Nguyen Phuong
Keyword(s):  
Sleep Quality ◽  
Cancer Patients ◽  
Linear Regression Analysis ◽  
Anxiety And Depression ◽  
Poor Sleep ◽  
Quality Of Sleep ◽  
Poor Sleep Quality ◽  
Related Factors ◽  
Falling Asleep

TÓM TẮT Giới thiệu: Các rối loạn về giấc ngủ: khó khăn khi đi vào giấc ngủ, duy trì giấc ngủ, chất lượng giấc ngủ kém, dậy sớm và ngủ ban ngày quá nhiều mà bệnh nhân ung thư phải trải qua thường xuyên nhưng thường hay bị bỏ sót và chưa được chú ý đến. Mục tiêu: Đánh giá chất lượng giấc ngủ và tìm hiểu các yếu tố liên quan đến chất lượng giấc ngủ ở bệnh nhân ung thư đang được điều trị tại bệnh viện trường đại học Y dược Huế. Phương pháp nghiên cứu: Phương pháp nghiên cứu cắt ngang trên 104 bệnh nhân ung thư tại Khoa Ung Bướu, bệnh viện trường Đại học Y dược Huế. Sử dụng thang đo PSQI và PHQ-ADS để đánh giá chất lượng giấc ngủ, và tình trạng trầm cảm lo âu ở bệnh nhân ung thư. Phân tích hồi quy đa biến tuyến tính dùng để kiểm định mối tương quan giữa chất lượng giấc ngủ và các yếu tố liên quan. Kết quả: Đối tượng nghiên cứu có độ tuổi trung bình 59,6 ± 11,7. Điểm PSQI trung bình chất lượng giấc ngủ là 10,6 ± 5,2. Phần lớn bệnh nhân có chất lượng giấc ngủ kém (79,8%); trong đó, 50% bệnh nhân gặp trở ngại lớn để đi vào giấc ngủ, có đến 46,2% chỉ ngủ được 5 giờ trong một đêm. Có mối liên quan có ý nghĩa thống kê giữa chất lượng giấc ngủ với giới tính và tình trạng trầm cảm, lo âu (p < 0,05). Kết luận: Bệnh nhân ung thư thường có chất lượng giấc ngủ kém. Điều này cho thấy giấc ngủ của bệnh nhân cần được quan tâm đúng mức và không nên bỏ sót trong quá trình chẩn đoán và điều trị. Từ khóa: Chất lượng giấc ngủ, bệnh nhân ung thư, trầm cảm lo âu. ABSTRACT QUALITY OF SLEEP AND RELATED FACTORS AMONG CANCER PATIENTS IN HUE UNIVERSITY HOSPITAL Introduction: Sleep disorders such as difficulty in falling asleep, maintaining sleep, poor sleep efficiency, early awakening and excessive daytime sleepiness are among the adverse effects that are experienced frequently but they are widely underdiagnosed. Therefore, addressing problems related to sleep among cancer patients could carry out better implications to improve quality of sleep, enhancing treatment outcomes. Aim: To evaluate quality of sleep and to detect associated factors of sleep quality among cancer patients. Methods: The cross-sectional study was conducted among 104 cancer patients treated at the Oncology Department, Hue University of Medicine and Pharmacy hospital. Sleep quality (Pittsburgh Sleep Quality Index), severity of anxiety and depression (Patient Health Questionnaire - Anxiety and Depression Scale) were accessed in the present study. Linear regression analysis was used to investigate the association between sleep quality and its related factors. Results: The mean age of study population was 59.6 ± 11.7. The average PSQI score was 10.6 ± 5.2. 79.8% cancer patients had poor sleep quality (PSQI score > 5). 50% patients had difficulty falling asleep and 46.2% patients reported sleep of < 5 hours per day. There were statistically associations between quality of sleep and gender, depression/anxiety (p < 0.05). Conclusion: The majority of cancer patients had poor sleep quality. This study points out that sleep is of great importance among cancer patients, which should not be neglected during the diagnosis and treatment procedure. Keyword: Quality of sleep, cancer patient, depression, anxiety.

Factors affecting sleep quality and its association to quality of life in adult Filipinos with cancer.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e23100-e23100
Author(s):  
Amabelle Trina Borgonia Gerona ◽  
Ryelene Baquilod ◽  
Deborah A. Bernardo ◽  
Roselle B. De Guzman
Keyword(s):  
Quality Of Life ◽  
Sleep Quality ◽  
Sleep Disturbance ◽  
Cancer Patients ◽  
Advanced Disease ◽  
Poor Sleep ◽  
Quality Of Sleep ◽  
Poor Sleep Quality ◽  
Factors Affecting

e23100 Background: Sleep disturbances are highly prevalent in cancer patients and may be attributable to factors including pain, treatment side effects and psychological factors. However, the relationship between sleep and cancer is bidirectional. There is substantial evidence that sleep disturbance is associated with many aspects of cancer treatment, morbidity, mortality and quality of life. This study evaluated sleep quality in adult Filipinos with cancer and determined the association of demographic characteristics and clinical features to sleep quality. Methods: This was a cross-sectional surveillance study conducted among adult Filipinos with cancer seen at the Ambulatory Care Unit of a tertiary hospital. Questionnaires were answered to assess subjective sleep quality, pain score and quality of life. Frequency and percentages were determined. Determination of factors affecting sleep quality was analyzed using univariate and multivariate statistics. Results: Of the 406 cancer patients studied, 80% were women and the mean age was 53 years old. Majority (62%) had breast cancer. Seventy-nine percent (79%) of the patients had a PSQI score of 5 or greater, indicating poor sleep quality. Sleep among participants was characterized by prolonged time to fall asleep and shortened sleep duration. Majority reported some degree of daytime dysfunction due to poor sleep. Age, gender and marital status did not appear to affect the quality of sleep. Among disease-related factors, presence of more advanced disease, increasing pain severity and treatment with chemotherapy and/or radiotherapy were demonstrated to lead to poorer sleep quality. Surprisingly, even patients who were not receiving any active therapies (on-going surveillance) complained of sleep disturbance. Upon further investigation, poor sleep quality was shown to predict a worse quality of life among the study participants. Conclusions: Overall, the quality of sleep among adult Filipinos with cancer is significantly impaired. In particular, presence of more advanced disease, treatment with chemotherapy and radiotherapy and moderate to severe pain significantly increase the risk of having poor sleep. In turn, disturbed sleep predicted a poorer quality of life. These findings support the need to include assessment of sleep quality for a more holistic approach to cancer care.

scholarly journals O031 Nocturnal melatonin secretion in post-treatment breast cancer patients: a preliminary study

2021 ◽  
Vol 2 (Supplement_1) ◽  
pp. A14-A14
Author(s):  
H Subramanian ◽  
V Fuchsova ◽  
H Man ◽  
R Trivedi ◽  
E Elder ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Sleep Quality ◽  
Cancer Patients ◽  
Post Treatment ◽  
Poor Sleep ◽  
Breast Cancer Patients ◽  
Melatonin Secretion ◽  
Poor Sleep Quality ◽  
Salivary Melatonin ◽  
Post Menopausal

Abstract Purpose Breast-cancer patients frequently report of poor sleep-quality. Although the pathophysiology is unclear, circadian-sleep misalignment is a plausible mechanism. We compared nocturnal melatonin-secretion, a circadian rhythm marker, in post-menopausal, post-treatment (≥12-months) female breast-cancer patients (BCG), with post-menopausal female controls with no history of cancer (CG) Methods We recruited 6 BCG and 10 CG from Westmead Hospital breast-cancer outpatient clinic or hospital-staff community, respectively. Participants completed the Pittsburgh Sleep Quality Index (PSQI; &gt;5 PSQI-score=poor sleep-quality) and ~7 days of home-actigraphy (Philips Actiwatch-2, Philips Respironics, USA) to ascertain habitual bed-time (HBT). Later, participants completed an overnight, in-laboratory study, with saliva sampled (n=13) at regular intervals under strict dim-light conditions (&lt;1 lux). Salivary-melatonin concentrations were quantified via radioimmunoassay (University of Adelaide). We measured 1) clock-time when salivary-melatonin concentrations reached 4pg/mL (melatonin onset-[DLMO-4pg/ml]) and 2) time-interval between HBT and DLMO-4pg/ml (indicates circadian-sleep misalignment-[PAR-DLMO]). Data were expressed as median [interquartile range], and compared using 2-sided Mann Whitney U-tests. p&lt;0.05 was considered significant. Results BCG and CG had similar ages (62.5 [59.5–67.3] vs. 58.5 [54.0–66.3] yrs, respectively; p=0.23). Compared with CG, BCG had higher PSQI-scores (8.50 [5.25–10.75] vs. 4.00 [3.75–5.50] a.u.; p=0.07), but similar HBT (22:49 [21:46-23:38] vs. 22:17 [21:59-22:21] h:min; p=0.26). BCG had later DLMO-4pg/ml (20:46 [20:01-22:03] vs. 18:23 [17:55-20:07] h:min; p=0.03) and shorter PAR-DLMO (1.43 [0.96–2.38] vs. 3.63 [2.18–3.90] hrs; p=0.09), than CG. Conclusion Preliminary data indicate BCG had poorer sleep-quality, delayed melatonin onset, and altered circadian-sleep alignment; compared with CG. We speculate disrupted nocturnal melatonin-secretion potentially influences poor sleep-quality reported by breast-cancer patients.

scholarly journals Sleep Quality and Cancer-Related Fatigue in Patients with Cancer

2021 ◽  
Vol 10 (3) ◽  
pp. 145-152
Author(s):  
Mahdieh Momayyezi ◽  
Hossein Fallahzadeh ◽  
Fatemeh Farzaneh ◽  
Mohammad Momayyezi
Keyword(s):  
Sleep Quality ◽  
Cancer Patients ◽  
Sleep Problems ◽  
Poor Sleep ◽  
Poor Sleep Quality ◽  
Test Analysis ◽  
Patients With Cancer ◽  
Cancer Related Fatigue ◽  
The Mean ◽  
Age Range

Introduction: Sleep problems and fatigue are common symptoms reported by cancer patients. In this study, the researchers used a specialized tool to measure fatigue in cancer patients and its relationship with sleep quality in Yazd, Iran. Methods: This descriptive correlational study included 149 cancer patients (age range: over 18 years) referred to Shahid Sadoughi Hospital in Yazd, Iran. Data were collected by the Pittsburgh Sleep Quality Index (PSQI) and Cancer-Related Fatigue Questionnaire. A PSQI score of ≥5 indicated a poor sleep. Data were analyzed using SPSS Statistics for Windows, version 13.0 (SPSS Inc., Chicago, IL, USA), Pearson’s correlation, t test, analysis of variance (ANOVA), and linear regression. Results: The mean (SD) PSQI score of patients was 13 (4.85) out of 21. About 69.3% of patients had a poor sleep quality. While the mean (SD) of sleep duration was 5.57 (0.54) hours, it was 69.44 (46.58) minutes for sleep latency. Also, with increasing the mean of sleep quality, the mean of fatigue significantly increased (P<0.001, R=0.63). Conclusion: According to the results, there was a relationship between the sleep quality and fatigue in cancer patients, so that patients with better sleep quality had less fatigue.

scholarly journals Factors Affecting Sleep Quality of Breast Cancer Patients with Chemotherapy

2021 ◽  
Vol 9 (T4) ◽  
pp. 130-136
Author(s):  
Diyanah Syolihan Rinjani Putri ◽  
Sri Nabawiyati Nurul Makiyah
Keyword(s):  
Breast Cancer ◽  
Sleep Quality ◽  
Cancer Patients ◽  
Nuclear Family ◽  
Quality Data ◽  
Physiological Status ◽  
Poor Sleep ◽  
Breast Cancer Patients ◽  
Poor Sleep Quality ◽  
Correlation Test

BACKGROUND: Poor sleep quality becomes the effect of chemotherapy in breast cancer patients. AIM: This study aimed to examine the factors that influence breast cancer patients’ sleep quality undergoing chemotherapy. METHODS: This research used an observational method with cross-sectional design. There were 26 breast cancer patients undergoing chemotherapy at Djojonegoro Regional Hospital in Temanggung, Central Java. The characteristics of the respondent are recorded, including the demographic characteristics, respondents’ sleep quality, and the physiological status data of the respondent. The researchers use the Pittsburgh Sleep Quality Index (PSQI) to measure sleep quality. Data were analyzed using Kendall’s Tau and Spearman’s rank correlation test and the Pearson Product-Moment Correlation test. RESULTS: The result showed that breast cancer patients’ sleep quality is classified as poor with PSQI score of 10.96 ± 3.13. The average age of the respondent was 50.08 ± 7.31 years. The major characteristic of the respondent were 80.77% had married, 42.30% had elementary education, 61.54% did not work, and 61.54% had Rp 0, - income. Based on breast cancer patients undergoing chemotherapy, the respondents lived in rice field environment (42.30%), diagnosed with breast cancer <1 year (69.23%), had <1 year chemotherapy (96.15%), had under mastectomy on the left breast (80.76%), and underwent chemotherapy as much as 7.23 ± 4.80 times. Based on sleep quality, the respondents lived with nuclear family (61.54%), had no comorbidities (76.92%), did not consume other drugs (100%), did not consume sleeping pills (80.76%), and used lights during sleep (65.38%). There is a correlation between sleep quality and age and with whom the respondent lives in the same house. CONCLUSION: It was concluded that breast cancer patients undergoing chemotherapy had poor sleep quality, and the factors related to sleep quality were age and with whom the respondent lived in the same house.

Evaluating the prevalence and nature of sleep disturbances in prostate cancer patients receiving androgen deprivation therapy using a combination of actigraphy and sleep questionnaires.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e17046-e17046
Author(s):  
Stephen Mangar ◽  
Shalini Mondal ◽  
Steve Edwards ◽  
Hashim Uddin Ahmed ◽  
Richard J Wassersug ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Sleep Quality ◽  
Cancer Patients ◽  
Androgen Deprivation Therapy ◽  
Sleep Disturbances ◽  
Androgen Deprivation ◽  
Poor Sleep ◽  
Poor Sleep Quality ◽  
Treatment Naïve ◽  
Sleep Questionnaires

e17046 Background: Sleep disturbances and cancer related fatigue are commonly associated. Prostate cancer patients may suffer from disturbed sleep as a result of their diagnosis and following treatment, especially with androgen deprivation therapy (ADT). Wrist actigraphy is a non-invasive objective method of sleep data collection. This feasibility study compares sleep data obtained by actigraphy with subjective data from sleep questionnaires in order to determine the nature and severity of sleep disturbances in patients with and without ADT use. Methods: A prospective cross-sectional pilot study was conducted on 74 patients with prostate cancer attending a regional oncology clinic. Two validated subjective sleep questionnaires namely the Pittsburgh Sleep Quality Index [PSQI] and the Epworth Sleepiness Scale [ESS] were used. Patients wore actigraphy watches for a minimum of five consecutive days. The parameters of interest included: actual sleep time, sleep efficiency, fragmentation index, daytime napping frequency and duration. The questionnaire and actigraphy data were compared between 20 patients receiving ADT and 41 who were treatment-naive. Results: The compliance rate for completed actigraphy was 85%. Complete data sets with actigraphy and questionnaires were available from 61 patients. Those already receiving ADT were on LHRH analogues for a median duration of 2.35 years. Poor sleep quality as self-identified by patients from the PSQI (cut-off > 5) was 49% in the treatment-naive group which increased to 70% for those on ADT. For daytime sleepiness as assessed by ESS (cut-off > 10) this was 16% and 20% respectively. Actigraphy showed that patients on ADT reported longer sleep duration (7.4 vs 6.5 hours, p = 0.02), higher levels of nocturnal wakings (51.1% vs 36.7%, p = 0.002), with greater daytime napping duration (80.7mins vs 53.0mins, p = 0.04), and frequency (8.6 vs 5.6, p = 0.02) compared to treatment-naive patients. Conclusions: Self-reported poor sleep quality is common in prostate cancer patients, which appears worse for those receiving ADT. In patients receiving ADT, data derived from actigraphy suggests that although they were sleeping for longer at night, the quality of sleep was poor which, in turn, may be responsible for an increase in the frequency and duration of daytime napping. Based on the current findings, we recommend the use of actigraphy to characterise patients’ sleep patterns and to assess if sleep treatment is needed. Actigraphic data may allow for direct comparisons of different hormonal agents on sleep whilst identifying those with specific sleep disorders amenable to therapeutic intervention.

Sign in / Sign up

Export Citation Format

Share Document